According to USATODAY.com, In the updated guidance, the AHA and ASA recommend doctors consider using Ozempic and other GLP-1 drugs to reduce the risk of stroke in patients with diabetes and a high risk of heart disease. Full disclosure, I'm already taking a GLP 1 weight loss drug for yes weight loss and it is working
It was discovered in 2012,[3] by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide.[4] Clinical trials were started in 2015, and phase 3 was completed in 2016.[5] Researchers at the University of Leeds and Novo Nordisk reported in 2017 that it can also be used for the treatment of obesity.[6] It reduces hunger, food craving and body fat.[7] FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour.[8] On December 5, 2017, semaglutide was approved by the US FDA
Weve seen interest in fibres with higher digestive tolerance that ferment later in the gut
Sepsis: pathophysiology and clinical management
MEDICAL DISCLAIMER : Educational content only
You specify each dose amount and the date administered